Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Clinical trial NCT01039376 · TERMINATED
Trial details
- NCT number
- NCT01039376
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-06
- Primary completion
- 2017-02-20
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.